Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-09-18

FDA Approved: BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for the analgesic combination Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate from Actavis, indicating an app…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Butalbital, Acetaminophen, Caffeine and Codeine Phosphate

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE (BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE)